ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI)
CUSIP: 774374300
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 89,116,466
- Total 13F shares
- 9,458,711
- Share change
- +3,179,689
- Total reported value
- $37,550,900
- Put/Call ratio
- 13%
- Price per share
- $3.97
- Number of holders
- 51
- Value change
- +$12,647,404
- Number of buys
- 41
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 774374300?
CUSIP 774374300 identifies RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 774374300:
Top shareholders of RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.6%
|
3,221,640
|
$5,670,086 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
1,118,277
|
$1,968,167 | — | 30 Jun 2024 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.39%
|
350,409
|
$617,000 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
305,349
|
$537,548 | — | 30 Jun 2024 | |
| Richmond Brothers, Inc. |
13F
|
Company |
0.31%
|
276,828
|
$487,209 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.25%
|
218,721
|
$384,949 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.2%
|
181,356
|
$319,000 | — | 30 Jun 2024 | |
| John Peter Mclaughlin |
3/4/5
|
Director |
—
mixed-class rows
|
209,831
mixed-class rows
|
$191,764 | — | 17 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
103,828
|
$182,737 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
102,700
|
$180,752 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
78,204
|
$137,639 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
63,786
|
$112,263 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
47,769
|
$84,073 | — | 30 Jun 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.04%
|
32,698
|
$58,000 | — | 30 Jun 2024 | |
| WealthTrust Axiom LLC |
13F
|
Company |
0.04%
|
31,500
|
$55,440 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
28,839
|
$50,757 | — | 30 Jun 2024 | |
| SkyOak Wealth, LLC |
13F
|
Company |
0.03%
|
25,070
|
$44,123 | — | 30 Jun 2024 | |
| Paul E. McGarry |
3/4/5
|
SVP, Finance and CAO |
—
mixed-class rows
|
65,725
mixed-class rows
|
$39,921 | — | 17 Mar 2023 | |
| Marc L. Hoffman |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
58,655
mixed-class rows
|
$35,931 | — | 17 Mar 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
19,533
|
$34,378 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
15,971
|
$28,109 | — | 30 Jun 2024 | |
| Cetera Investment Advisers |
13F
|
Company |
0.02%
|
14,127
|
$24,864 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.02%
|
13,590
|
$23,917 | — | 30 Jun 2024 | |
| TRAPHAGEN INVESTMENT ADVISORS LLC |
13F
|
Company |
0.01%
|
11,100
|
$19,536 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
10,703
|
$18,837 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,428
|
$2,513 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
590
|
$1,038 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
339
|
$597 | — | 30 Jun 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
288
|
$507 | — | 30 Jun 2024 | |
| Rise Advisors, LLC |
13F
|
Company |
0%
|
215
|
$378 | — | 30 Jun 2024 | |
| COMERICA BANK |
13F
|
Company |
0%
|
163
|
$287 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
35
|
$62 | — | 30 Jun 2024 | |
| Russell H. Ellison |
3/4/5
|
President and Chief Executive Officer, Director |
—
class O/S missing
|
200,000
|
— | — | 03 May 2021 | |
| Raymond Dennis Pratt |
3/4/5
|
Chief Development Officer |
—
class O/S missing
|
112,500
|
— | — | 03 May 2021 | |
| Russell Skibsted |
3/4/5
|
EVP, Chief Financial Officer and Chief Business Officer |
—
class O/S missing
|
80,000
|
— | — | 09 Sep 2022 |
Institutional Holders of ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) as of Q3 2024
As of 30 Sep 2024,
ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,458,711 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GLOBEFLEX CAPITAL L P, MARSHALL WACE, LLP, PERKINS CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Richmond Brothers, Inc., BlackRock, Inc., AMERIPRISE FINANCIAL INC, and EAM Investors, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
29
Q3 2024 holders
51
Holder diff
22
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.